Plasminogen possess great potential to treat diabetic and chronic wounds

The study conducted by a group of scientific investigators of the Umea University led the invention of the new drug, which resulted due to their findings of a plasminogen protein that plays a central role in the commencement and acceleration of wound

Fontana, CA (prHWY.com) June 6, 2012 - 6 June 2012, USA(Realpharmacyrx.co): Researchers develop an exceptional and distinctive medication that possesses the ability to initiate as well as fasten up the healing process wounds caused in some chronic and diabetic complications. The drug that was produced successfully after several years of diligent experimental research is currently ready to undergo medical testing.
The study conducted by a group of scientific investigators of the Umea University led the invention of the new drug, which resulted due to their findings of a plasminogen protein that plays a central role in the commencement and acceleration of wound healing process by activating the inflammatory reaction.

Professor Tor Ny, one of the authors of the study said in his interview that a massive chunk of the research study has been accomplished, except for the fact that clinical evaluation is in its stages of discussion and that can be completed successfully, once proper funding and approval is obtained.
He also said that the basic knowledge to develop a medication is being acquired by them and if things go in the proper direction that the drug will be in the market soon. The concentration of plasminogen, (a plasma protein produced by the liver) increases drastically in the surrounding area of wounds, which signals the inflammatory reaction to initiate the healing process.
Whereas, in case of individuals with diabetic wounds; plasminogen levels were not found to increase significantly, thereby hindering the wound healing mechanism. Injecting plasminogen near the wound area was found to initiate the healing process as well as completion of the task successfully was observed by the researchers in laboratory mice.
The development of the drug may prove a sigh of relief for all those 350 million diabetic individuals around the world suffering from foot ulcers. Also, the inability of an effective clinical medication to heal the wounds caused in diabetic individuals has led to amputation of around 10-15 million patients.
This study provides a great hope to millions of diabetic individuals as well as those suffering from various chronic infections.
For more please visit us: http://www.realpharmacyrx.co/augmentin.html
http://realpharmacyrxco.blogspot.in/

###

Tag Words: generic drug store, generic pharmacy online, augmentin

Categories: Health

Press Release Contact
http://www.realpharmacyrx.co/

Link To This Press Release:

URL HTML Code